论文部分内容阅读
目的:探讨分析来氟米特医治肾内科疾病的临床疗效。方法:选取我院于2016年7月至2017年2月收治的肾内科疾病患者120例,根据起治疗方法的不同,将其随机分成常规(对照)组与特效(观察)组,每组患者均为60例,常规组患者接受常规治疗,特效组则在常规治疗的基础上加上来氟米特,分析比较两组肾内科疾病患者的临床治疗效果以及不良反应。结果:经过不同方式的治疗后,特效组的临床治疗有效率为96.67%,明显高于常规组的治疗有效率83.33%且比较差异具有统计学意义,即P<0.05。结论:应用来氟米特对肾脏病患者加以治疗能明显提高患者临床治疗的有效率,且较为安全,值得广大医者借鉴及推广。
Objective: To investigate the clinical efficacy of leflunomide in the treatment of renal diseases. Methods: One hundred and twenty patients with nephrologic diseases admitted in our hospital from July 2016 to February 2017 were randomly divided into routine (control) and special effects (observation) groups according to the different treatment methods. Each group of patients All of them were 60 cases. Patients in the conventional group received conventional treatment. The special effects group was given leflunomide on the basis of routine treatment. The clinical effects and adverse reactions of the patients in the two groups were analyzed and compared. Results: After treatment by different ways, the effective rate of clinical treatment in the special treatment group was 96.67%, which was significantly higher than that in the conventional treatment group (83.33%). The difference was statistically significant (P <0.05). Conclusion: The application of leflunomide in the treatment of patients with kidney disease can significantly improve the efficiency of clinical treatment of patients, and more secure, it is worth the majority of doctors to learn and promote.